Cargando…
The challenges of oral drug delivery via nanocarriers
The oral application of pharmaceuticals is unarguably the most convenient method of application. Especially for protein- or peptide-based drugs, however, the effectiveness is significantly reduced due to enzymatic digestion in the stomach as well as a poor bioavailability in the small intestine. For...
Autores principales: | Reinholz, Jonas, Landfester, Katharina, Mailänder, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225504/ https://www.ncbi.nlm.nih.gov/pubmed/30394120 http://dx.doi.org/10.1080/10717544.2018.1501119 |
Ejemplares similares
-
Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
por: Schunke, Jenny, et al.
Publicado: (2023) -
Silica Nanocapsules with Different Sizes and Physicochemical Properties as Suitable Nanocarriers for Uptake in T-Cells
por: Thiramanas, Raweewan, et al.
Publicado: (2020) -
Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell Functions
por: Thiramanas, Raweewan, et al.
Publicado: (2020) -
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets
por: Brückner, Maximilian, et al.
Publicado: (2022) -
Prevention of Dominant IgG Adsorption on Nanocarriers in IgG‐Enriched Blood Plasma by Clusterin Precoating
por: Prozeller, Domenik, et al.
Publicado: (2019)